biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > My How Time Flies When You Are Having Fun!

<< Previous

Bullboard Posts

Next >>

Comment by DeadMonkeyon May 04, 2023 11:39am

76 Views

Post# 35430157

RE:RE:RE:RE:My How Time Flies When You Are Having Fun!

ever wrote that xb3 didnt work or was an issue. it is quite the contrary.

you may have asked but it has been clear over the years that they were not alawys honest with you. you have no idea what actual agreements they had or didn't have.you had to go by whatever management at the time was in place told you. i'm well aware what a meterial transfer agreement is and that is not what im referring to.you do not know as much as you think you know. you only know what they let you know or wanted you to know. don't be so quick to claim you do or to discount others.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale